Bharat Immunological & Biological Corporation has informed about draft 29th Annual Report in respect of financial year ending on 31 03 2018 will be placed at Annual General Meeting for approval by shareholders on 28.09.2018.
The above information is a part of company’s filings submitted to BSE.